Number of Cardiologists per Cardiovascular Beds and In-Hospital Mortality for Acute Heart Failure: A Nationwide Study in Japan.


Journal

Journal of the American Heart Association
ISSN: 2047-9980
Titre abrégé: J Am Heart Assoc
Pays: England
ID NLM: 101580524

Informations de publication

Date de publication:
17 09 2019
Historique:
entrez: 10 9 2019
pubmed: 10 9 2019
medline: 15 9 2020
Statut: ppublish

Résumé

Background Little evidence is available about the number of cardiologists required for appropriate treatment of heart failure (HF). Our objective was to determine the association between the number of cardiologists per cardiology beds for treating patients with acute HF and in-hospital mortality. Methods and Results This was a cross-sectional study, and we used the Japanese Registry of All Cardiac and Vascular Diseases Diagnosis Procedure Combination discharge database. The data of patients with HF on emergency admission from April 1, 2012, to March 31, 2014, were extracted. The patients were categorized into 4 groups by the quartiles of the numbers of cardiologists per 50 cardiovascular beds (first group: median, 4.4 [interquartile range, 3.5-5.0]; second group: median, 6.7 [interquartile range, 6.5-7.5]; third group: median, 9.7 [interquartile range, 8.8-10.1]; and fourth group: median, 16.7 [interquartile range, 14.0-23.8]). Using multilevel mixed-effect logistics regression, we determined adjusted odds ratios for in-hospital mortality. We identified 154 290 patients with HF on emergency admissions. There were 29 626, 36 587, 46 451, and 41 626 patients in the first, second, third, and fourth groups, respectively. HF severity, on the basis of New York Heart Association classification, was similar in the 3 groups. Adjusted odds ratios (95% CIs) for in-hospital mortality were 0.92 (0.82-1.04; P=0.20), 0.82 (0.72-0.92; P<0.001), and 0.70 (0.61-0.80; P<0.001) for the second, third, and fourth groups, respectively. The proportion of medication used, including angiotensin-converting enzyme inhibitors or angiotensin receptor blockers, β blockers, and mineralocorticoid receptor antagonists, was positively correlated to the number of cardiologists. Conclusions Patients hospitalized for HF in hospitals with larger numbers of cardiologists per cardiovascular beds had lower 30-day mortality.

Identifiants

pubmed: 31495302
doi: 10.1161/JAHA.119.012282
pmc: PMC6818015
doi:

Substances chimiques

Adrenergic beta-Antagonists 0
Angiotensin Receptor Antagonists 0
Angiotensin-Converting Enzyme Inhibitors 0
Mineralocorticoid Receptor Antagonists 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e012282

Références

BMJ. 2014 May 05;348:g3072
pubmed: 24803082
J Am Heart Assoc. 2017 Nov 29;6(12):
pubmed: 29187385
Chest. 1999 Aug;116(2):346-54
pubmed: 10453861
Clin Cardiol. 2017 Feb;40(2):109-119
pubmed: 27862089
JAMA Intern Med. 2015 Jun;175(6):996-1004
pubmed: 25895156
Circ Heart Fail. 2013 Sep 1;6(5):890-7
pubmed: 23926203
Lancet. 2018 Feb 10;391(10120):572-580
pubmed: 29174292
Stroke. 2005 Sep;36(9):1984-7
pubmed: 16081854
J Am Coll Cardiol. 2013 Mar 26;61(12):1259-67
pubmed: 23500328
Circ J. 2016 Oct 25;80(11):2327-2335
pubmed: 27725417
Eur Heart J. 2016 Jul 14;37(27):2129-2200
pubmed: 27206819
N Engl J Med. 2010 Mar 25;362(12):1110-8
pubmed: 20335587
Circ Cardiovasc Qual Outcomes. 2009 Sep;2(5):407-13
pubmed: 20031870
Int Heart J. 2005 Sep;46(5):855-66
pubmed: 16272776
Circulation. 2018 Sep 4;138(10):965-967
pubmed: 30354536
Vasc Health Risk Manag. 2008;4(1):103-13
pubmed: 18629369
BMJ Open. 2014 Dec 30;4(12):e005988
pubmed: 25550294
Eur Heart J. 2008 Oct;29(19):2388-442
pubmed: 18799522
J Am Heart Assoc. 2019 Sep 17;8(18):e012282
pubmed: 31495302
Circulation. 2017 Aug 8;136(6):e137-e161
pubmed: 28455343

Auteurs

Koshiro Kanaoka (K)

Department of Cardiovascular Medicine Nara Medical University Nara Japan.

Satoshi Okayama (S)

Department of Cardiovascular Medicine Nara Medical University Nara Japan.

Michikazu Nakai (M)

National Cerebral and Cardiovascular Center Suita Japan.

Yoko Sumita (Y)

National Cerebral and Cardiovascular Center Suita Japan.

Kenji Onoue (K)

Department of Cardiovascular Medicine Nara Medical University Nara Japan.

Tsunenari Soeda (T)

Department of Cardiovascular Medicine Nara Medical University Nara Japan.

Kunihiro Nishimura (K)

National Cerebral and Cardiovascular Center Suita Japan.

Rika Kawakami (R)

Department of Cardiovascular Medicine Nara Medical University Nara Japan.

Hiroyuki Okura (H)

Department of Cardiovascular Medicine Nara Medical University Nara Japan.

Yoshihiro Miyamoto (Y)

National Cerebral and Cardiovascular Center Suita Japan.

Satoshi Yasuda (S)

National Cerebral and Cardiovascular Center Suita Japan.

Hiroyuki Tsutsui (H)

Department of Cardiovascular Medicine Kyushu University Graduate School of Medical Sciences Fukuoka Japan.

Issei Komuro (I)

Department of Cardiovascular Medicine The University of Tokyo Graduate School of Medicine Tokyo Japan.

Hisao Ogawa (H)

National Cerebral and Cardiovascular Center Suita Japan.

Yoshihiko Saito (Y)

Department of Cardiovascular Medicine Nara Medical University Nara Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH